Prevalence of cardiovascular disease risk factors and their association with outcomes in working-age patients with arterial hypertension
- Authors: Galyavich A.S.1, Khairullin R.N.2, Baleeva L.V.1, Mamedova A.K.1, Sabirzyanova A.A.1, Galeeva Z.M.1, Galimzyanov A.F.2
-
Affiliations:
- Kazan State Medical University, Ministry of Health of Russia
- Interregional Clinical Diagnostic Center
- Issue: Vol 35, No 9 (2024)
- Pages: 72-76
- Section: From Practice
- URL: https://journal-vniispk.ru/0236-3054/article/view/266795
- DOI: https://doi.org/10.29296/25877305-2024-09-15
- ID: 266795
Cite item
Abstract
Most epidemiological studies are devoted to studying the prevalence of risk factors (RFs) for cardiovascular diseases (CVD) in the general population, but this problem has not been sufficiently studied in people of working age.
Purpose. To study the prevalence of CVD risk factors and their relationship with outcomes in working-age patients with arterial hypertension (AH).
Material and methods. Data from 13,994 working-age patients with hypertension who were observed on an outpatient basis were analyzed. The analysis was carried out according to the following CVD risk factors: gender, age, body mass index (BMI), smoking history, diabetes mellitus (DM), levels of systolic and diastolic blood pressure (BP), cholesterol, glucose, glomerular filtration rate, risk on the SCORE scale. The effect of risk factors on unfavorable outcome of the disease was also studied.
Results. Patients with AH of working age, who were observed and treated on an outpatient basis, had fairly good control of AH (average values – 135/80 mm Hg). Women had lower systolic BP, total cholesterol levels and BMI were higher than men. Men were more likely to have a history of smoking and T2DM. Among all patients, T2DM was detected in 4.7% of cases, while patients with DM were older in age, had a higher BMI, and were more likely to smoke compared to patients without DM. In patients with T2DM, BP control was better (average value – 130/80 mm Hg), the level of total cholesterol did not differ significantly from patients without DM. During the observation period, 234 (1.7%) patients died (from coronary heart disease – 69.7%, from CVD – 30.3%). The following risk factors for unfavorable outcome were identified: age, male gender, increased systolic BP, smoking, presence of diabetes, increased risk score on the SCORE scale.
Full Text
##article.viewOnOriginalSite##About the authors
A. S. Galyavich
Kazan State Medical University, Ministry of Health of Russia
Email: larisabaleeva151@gmail.com
ORCID iD: 0000-0002-4510-6197
Doctor of Medical Sciences, Professor
Russian Federation, KazanR. N. Khairullin
Interregional Clinical Diagnostic Center
Email: larisabaleeva151@gmail.com
ORCID iD: 0000-0003-0788-4024
Doctor of Medical Sciences
Russian Federation, KazanL. V. Baleeva
Kazan State Medical University, Ministry of Health of Russia
Author for correspondence.
Email: larisabaleeva151@gmail.com
ORCID iD: 0000-0002-7974-5894
Candidate of Medical Sciences
Russian Federation, KazanA. Kh. Mamedova
Kazan State Medical University, Ministry of Health of Russia
Email: larisabaleeva151@gmail.com
ORCID iD: 0000-0001-9107-2998
Russian Federation, Kazan
A. A. Sabirzyanova
Kazan State Medical University, Ministry of Health of Russia
Email: larisabaleeva151@gmail.com
ORCID iD: 0000-0002-2130-0593
Candidate of Medical Sciences
Russian Federation, KazanZ. M. Galeeva
Kazan State Medical University, Ministry of Health of Russia
Email: larisabaleeva151@gmail.com
ORCID iD: 0000-0002-9580-3695
Candidate of Medical Sciences, Associate Professor
Russian Federation, KazanA. F. Galimzyanov
Interregional Clinical Diagnostic Center
Email: larisabaleeva151@gmail.com
ORCID iD: 0000-0003-1578-7814
Candidate of Medical Sciences
Russian Federation, KazanReferences
- Бойцов С.А., Погосова Н.В., Аншелес А.А. и др. Кардиоваскулярная профилактика 2022. Российские национальные рекомендации. Российский кардиологический журнал. 2023; 28 (5): 5452 [Boytsov S.A., Pogosova N.V., Ansheles A.A. et al. Cardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology. 2023; 28 (5): 5452 (in Russ.)]. doi: 10.15829/1560-4071-2023-5452
- Кобалава Ж.Д., Конради А.О., Недогода С.В. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25 (3): 3786 [Kobalava Zh.D., Konradi A.O., Nedogoda S.V. et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020; 25 (3): 3786 (in Russ.)]. doi: 10.15829/1560-4071-2020-3-3786
- Российский статистический ежегодник, 2023. М., 2023; 701 с. [Russian Statistical Yearbook, 2023. Moscow, 2023; 701 p. (in Russ.)].
- Здравоохранение в России, 2023. М., 179 с. [Healthcare in Russia, 2023. M., 179 p. (in Russ.)].
- Garland A., Jeon S.H., Stepner M. et al. Effects of cardiovascular and cerebrovascular health events on work and earnings: a population-based retrospective cohort study. CMAJ. 2019; 191 (1): E3-E10. doi: 10.1503/cmaj.181238
- Баланова Ю.А., Драпкина О.М., Куценко В.А. и др. Артериальная гипертония в российской популяции в период пандемии COVID-19: гендерные различия в распространенности, лечении и его эффективности. Данные исследования ЭССЕ-РФ3. Кардиоваскулярная терапия и профилактика. 2023; 22 (8S): 3785 [Balanova Yu.A., Drapkina O.M., Kutsenko V.A. et al. Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023; 22 (8S): 3785 (in Russ.)]. doi: 10.15829/1728-8800-2023-3785
- Галявич А.С., Хайруллин Р.Н., Балеева Л.В. и др. Факторы риска ишемической болезни сердца у 27425 амбулаторных пациентов. Российский кардиологический журнал. 2019; 6: 23–6 [Galyavich A.S., Khairullin R.N., Baleeva L.V. et al. Risk factors of coronary artery disease in 27425 outpatients. Russian Journal of Cardiology. 2019; 6: 23–6 (in Russ.)]. doi: 10.15829/1560-4071-2019-6-23-26
- Ежов М.В., Кухарчук В.В., Сергиенко И.В. и др. Нарушения липидного обмена. Клинические рекомендации 2023. Российский кардиологический журнал. 2023; 28 (5): 5471 [Ezhov M.V., Kukharchuk V.V., Sergienko I.V. et al. Disorders of lipid metabolism. Clinical Guidelines 2023. Russian Journal of Cardiology. 2023; 28 (5): 5471 (in Russ.)]. doi: 10.15829/1560-4071-2023-5471
- Драпкина О.М., Имаева А.Э., Куценко В.А. и др. Дислипидемии в Российской Федерации: популяционные данные, ассоциации с факторами риска. Кардиоваскулярная терапия и профилактика. 2023; 22 (8S): 3791 [Drapkina O.M., Imaeva A.E., Kutsenko V.A. et al. Dyslipidemia in the Russian Federation: population data, associations with risk factors. Cardiovascular Therapy and Prevention. 2023; 22 (8S): 3791 (in Russ.)]. doi: 10.15829/1728-8800-2023-3791
- Баланова Ю.А., Драпкина О.М., Куценко В.А. и др. Ожирение в российской популяции в период пандемии COVID-19 и факторы, с ним ассоциированные. Данные исследования ЭССЕ-РФ3. Кардиоваскулярная терапия и профилактика. 2023; 22 (8S): 3793 [Balanova Yu.A., Drapkina O.M., Kutsenko V.A. et al. Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023; 22 (8S): 3793 (in Russ.)]. doi: 10.15829/1728-8800-2023-3793
- Драпкина О.М., Максимов С.А., Шальнова С.А. и др. Распространенность и динамика курения в России по данным исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2023; 22 (8S): 3790 [Drapkina O.M., Maksimov S.A., Shalnova S.A. et al. Prevalence of smoking and its changes over time in Russia: data from the ESSE-RF study. Cardiovascular Therapy and Prevention. 2023; 22 (8S): 3790 (in Russ.)]. doi: 10.15829/1728-8800-2023-3790
- Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под реда. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 11-й вып. М., 2023 [Algorithms of specialized medical care for patients with diabetes mellitus. Ed. by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 11th issue. М., 2023 (in Russ.)]. doi: 10.14341/DM13042
- Жернакова Ю.В. Чазова И.Е., Ощепкова Е.В. и др. Распространенность сахарного диабета в популяции больных артериальной гипертонией. По данным исследования ЭССЕ-РФ. Системные гипертензии. 2018; 15 (1): 56–62 [Zhernakova Yu.V., Chazova I.E., Oshchepkova E.V. et al. The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results. Systemic Hypertension. 2018; 15 (1): 56–62 (in Russ.)]. doi: 10.26442/2075-082X_15.1.56-62
Supplementary files
